A citation-based method for searching scientific literature

Bruno António Cardoso. Adv Exp Med Biol 2020
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.
Juan M Bergua, Pau Montesinos, David Martinez-Cuadrón, Pascual Fernández-Abellán, Josefina Serrano, María J Sayas, Julio Prieto-Fernandez, Raimundo García, Ana J García-Huerta, Manuel Barrios,[...]. Br J Haematol 2016
37
50

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.
William Blum, Ramiro Garzon, Rebecca B Klisovic, Sebastian Schwind, Alison Walker, Susan Geyer, Shujun Liu, Violaine Havelange, Heiko Becker, Larry Schaaf,[...]. Proc Natl Acad Sci U S A 2010
370
50

Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Narayanam V Rao, Brian Argyle, Xiaoyu Xu, Paul R Reynolds, Jeanine M Walenga, Margaret Prechel, Glenn D Prestwich, Robert B MacArthur, Bradford B Walters, John R Hoidal,[...]. Am J Physiol Cell Physiol 2010
104
50

The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.
M Abraham, S Klein, B Bulvik, H Wald, I D Weiss, D Olam, L Weiss, K Beider, O Eizenberg, O Wald,[...]. Leukemia 2017
64
50

Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia.
Yiqian Wang, Ying Xie, Jacob Williams, Yu Hang, Lisa Richter, Michelle Becker, Catalina Amador, David Oupický, R Katherine Hyde. Cancer Gene Ther 2020
9
50

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.
Marc Maynadié, Roberta De Angelis, Rafael Marcos-Gragera, Otto Visser, Claudia Allemani, Carmen Tereanu, Riccardo Capocaccia, Adriano Giacomin, Jean-Michel Lutz, Carmen Martos,[...]. Haematologica 2013
51
50

CXCR4 Antagonists: A Screening Strategy for Identification of Functionally Selective Ligands.
C Castaldo, T Benicchi, M Otrocka, E Mori, E Pilli, P Ferruzzi, S Valensin, D Diamanti, W Fecke, M Varrone,[...]. J Biomol Screen 2014
9
50

Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET.
Ido D Weiss, Lyn M Huff, Moses O Evbuomwan, Xin Xu, Hong Duc Dang, Daniel S Velez, Satya P Singh, Hongwei H Zhang, Paul J Gardina, Jae-Ho Lee,[...]. Oncotarget 2017
18
50

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
Zhihong Zeng, Yue Xi Shi, Ismael J Samudio, Rui-Yu Wang, Xiaoyang Ling, Olga Frolova, Mark Levis, Joshua B Rubin, Robert R Negrin, Elihu H Estey,[...]. Blood 2009
377
50

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
50

Pathophysiology of GvHD and Other HSCT-Related Major Complications.
Sakhila Ghimire, Daniela Weber, Emily Mavin, Xiao Nong Wang, Anne Mary Dickinson, Ernst Holler. Front Immunol 2017
82
50

[68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4.
Joseph Lau, Daniel Kwon, Etienne Rousseau, Zhengxing Zhang, Jutta Zeisler, Carlos F Uribe, Hsiou-Ting Kuo, Chengcheng Zhang, Kuo-Shyan Lin, François Bénard. Mol Pharm 2019
7
50

High CXCR4 and low VLA-4 expression predicts poor survival in adults with acute lymphoblastic leukemia.
Sun-Young Ko, Chan-Jeoung Park, Sang-Hyuk Park, Young-Uk Cho, Seongsoo Jang, Eul-Ju Seo, Nayoung Kim, Dae-Young Kim, Kyung Nam Koh, Ho Joon Im,[...]. Leuk Res 2014
19
50

Signaling Pathways in Leukemic Stem Cells.
Lindsay M Gurska, Kristina Ames, Kira Gritsman. Adv Exp Med Biol 2019
4
50

Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia.
Peter Herhaus, Stefan Habringer, Kathrin Philipp-Abbrederis, Tibor Vag, Carlos Gerngross, Margret Schottelius, Julia Slotta-Huspenina, Katja Steiger, Torben Altmann, Tanja Weißer,[...]. Haematologica 2016
34
50

Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML.
Edward Allan R Sison, Emily McIntyre, Daniel Magoon, Patrick Brown. Mol Cancer Res 2013
77
50

A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.
Nicholas J Short, Hagop Kantarjian, Farhad Ravandi, Xuelin Huang, Lianchun Xiao, Guillermo Garcia-Manero, William Plunkett, Varsha Gandhi, Koji Sasaki, Naveen Pemmaraju,[...]. Leuk Lymphoma 2018
13
50

Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J Briddon, Thierry Durroux, Stephen J Hill, Martin J Lohse, Graeme Milligan,[...]. Mol Pharmacol 2019
21
50

VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.
Mi Hyun Bae, Sung-Hee Oh, Chan-Jeoung Park, Bo-Ra Lee, Young Jin Kim, Young-Uk Cho, Seongsoo Jang, Je-Hwan Lee, Nayoung Kim, Sang Hyuk Park,[...]. Ann Hematol 2015
16
50

Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models.
Sheng-Bin Peng, Xiaoyi Zhang, Donald Paul, Lisa M Kays, Wendy Gough, Julie Stewart, Mark T Uhlik, Qi Chen, Yu-Hua Hui, Maciej J Zamek-Gliszczynski,[...]. Mol Cancer Ther 2015
84
50

Activity of the Aurora kinase inhibitor VX-680 against Bcr/Abl-positive acute lymphoblastic leukemias.
Fei Fei, Sonia Stoddart, John Groffen, Nora Heisterkamp. Mol Cancer Ther 2010
30
50

Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers.
Michal Abraham, Yaron Pereg, Baruch Bulvik, Shiri Klein, Inbal Mishalian, Hana Wald, Orly Eizenberg, Katia Beider, Arnon Nagler, Rottem Golan,[...]. Clin Cancer Res 2017
28
50

Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia.
Elwin J C Rombouts, Biljana Pavic, Bob Löwenberg, Rob E Ploemacher. Blood 2004
224
50

Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemia.
Tibor J Kovacsovics, Alice Mims, Mohamed E Salama, Jeremy Pantin, Narayanam Rao, Ken M Kosak, Peter Ahorukomeye, Martha J Glenn, Michael W N Deininger, Kenneth M Boucher,[...]. Blood Adv 2018
34
50

CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients.
Diane Goltz, Emily Eva Holmes, Heidrun Gevensleben, Verena Sailer, Jörn Dietrich, Maria Jung, Magda Röhler, Sebastian Meller, Jörg Ellinger, Glen Kristiansen,[...]. Oncotarget 2016
28
50



Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles.
Sergey G Tarasov, Vadim Gaponenko, O M Zack Howard, Yuhong Chen, Joost J Oppenheim, Marzena A Dyba, Sriram Subramaniam, Youngshim Lee, Christopher Michejda, Nadya I Tarasova. Proc Natl Acad Sci U S A 2011
37
50


CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.
Francesco Mannelli, Ilaria Cutini, Giacomo Gianfaldoni, Sara Bencini, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Maria Ida Bonetti, Caterina Biagiotti, Giovanni Longo,[...]. Cytometry B Clin Cytom 2014
13
50

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
Farhad Ravandi, Ellen K Ritchie, Hamid Sayar, Jeffrey E Lancet, Michael D Craig, Norbert Vey, Stephen A Strickland, Gary J Schiller, Elias Jabbour, Harry P Erba,[...]. Lancet Oncol 2015
105
50

CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation.
Aldo M Roccaro, Yuji Mishima, Antonio Sacco, Michele Moschetta, Yu-Tzu Tai, Jiantao Shi, Yong Zhang, Michaela R Reagan, Daisy Huynh, Yawara Kawano,[...]. Cell Rep 2015
93
50

Adult Acute Lymphoblastic Leukemia.
Shilpa Paul, Hagop Kantarjian, Elias J Jabbour. Mayo Clin Proc 2016
92
50


Peripheral blood stem cell mobilization; a look ahead.
Louis M Pelus, Hal E Broxmeyer. Curr Stem Cell Rep 2018
18
50

High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
R Crazzolara, A Kreczy, G Mann, A Heitger, G Eibl, F M Fink, R Möhle, B Meister. Br J Haematol 2001
157
50

Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist.
R Parameswaran, M Yu, M Lim, J Groffen, N Heisterkamp. Leukemia 2011
53
50


CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance.
Adam Greenbaum, Yen-Michael S Hsu, Ryan B Day, Laura G Schuettpelz, Matthew J Christopher, Joshua N Borgerding, Takashi Nagasawa, Daniel C Link. Nature 2013
821
50

First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.
Ken Herrmann, Margret Schottelius, Constantin Lapa, Theresa Osl, Andreas Poschenrieder, Heribert Hänscheid, Katharina Lückerath, Martin Schreder, Christina Bluemel, Markus Knott,[...]. J Nucl Med 2016
122
50

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
Prajwal Boddu, Gautam Borthakur, Mythili Koneru, Xuelin Huang, Kiran Naqvi, William Wierda, Prithviraj Bose, Elias Jabbour, Zeev Estrov, Jan Burger,[...]. Front Oncol 2018
16
50

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
Michael M B Green, Nelson Chao, Saurabh Chhabra, Kelly Corbet, Cristina Gasparetto, Ari Horwitz, Zhiguo Li, Jagadish Kummetha Venkata, Gwynn Long, Alice Mims,[...]. J Hematol Oncol 2016
17
50


A review on CXCR4/CXCL12 axis in oncology: no place to hide.
Urszula M Domanska, Roeliene C Kruizinga, Wouter B Nagengast, Hetty Timmer-Bosscha, Gerwin Huls, Elisabeth G E de Vries, Annemiek M E Walenkamp. Eur J Cancer 2013
412
50


IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML.
Belen Lopez-Millan, Rafael Diaz de la Guardia, Heleia Roca-Ho, Eduardo Anguita, Abul B M M K Islam, Damia Romero-Moya, Cristina Prieto, Francisco Gutierrez-Agüera, Jose Antonio Bejarano-Garcia, Jose Antonio Perez-Simon,[...]. Oncoimmunology 2018
10
50

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.
Bob Löwenberg, Wim van Putten, Matthias Theobald, Jurg Gmür, Leo Verdonck, Pieter Sonneveld, Martin Fey, Harry Schouten, Georgine de Greef, Augustin Ferrant,[...]. N Engl J Med 2003
308
50

Modulators of CXCR4 and CXCR7/ACKR3 Function.
Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon,[...]. Mol Pharmacol 2019
33
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.